CN103316219B - 一种治疗肺结核的中药制剂及其制备方法 - Google Patents
一种治疗肺结核的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN103316219B CN103316219B CN201310285174.2A CN201310285174A CN103316219B CN 103316219 B CN103316219 B CN 103316219B CN 201310285174 A CN201310285174 A CN 201310285174A CN 103316219 B CN103316219 B CN 103316219B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine preparation
- obtains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 70
- 239000003814 drug Substances 0.000 title claims abstract description 65
- 241000519406 Paphiopedilum Species 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 24
- 241001517299 Bulbophyllum Species 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
- 239000002245 particle Substances 0.000 claims description 40
- 239000011812 mixed powder Substances 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 230000001476 alcoholic effect Effects 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- 239000002105 nanoparticle Substances 0.000 claims description 10
- 238000005325 percolation Methods 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 239000002552 dosage form Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 238000005262 decarbonization Methods 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000012982 microporous membrane Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008215 water for injection Substances 0.000 claims description 5
- 206010011224 Cough Diseases 0.000 abstract description 42
- 210000004072 lung Anatomy 0.000 abstract description 38
- 210000003734 kidney Anatomy 0.000 abstract description 19
- 208000006673 asthma Diseases 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 9
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 235000009508 confectionery Nutrition 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 241000411851 herbal medicine Species 0.000 description 10
- 208000000616 Hemoptysis Diseases 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 230000002685 pulmonary effect Effects 0.000 description 6
- 201000005702 Pertussis Diseases 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 206010010741 Conjunctivitis Diseases 0.000 description 4
- 206010035664 Pneumonia Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000015817 Infant Nutrition disease Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 208000037656 Respiratory Sounds Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 206010037833 rales Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 239000002435 venom Substances 0.000 description 3
- 210000001048 venom Anatomy 0.000 description 3
- 231100000611 venom Toxicity 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025102 Lung infiltration Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- VRDIULHPQTYCLN-UHFFFAOYSA-N Prothionamide Chemical compound CCCC1=CC(C(N)=S)=CC=N1 VRDIULHPQTYCLN-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000003555 analeptic effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000024753 bloody sputum Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960000918 protionamide Drugs 0.000 description 1
- 229960005206 pyrazinamide Drugs 0.000 description 1
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
治愈 | 好转 | 无效 | 总有效 | ||
治疗组 | 41 | 6 | 33 | 2 | 39(95.12%) |
对照组 | 40 | 0 | 32 | 8 | 32(80.00%) |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310285174.2A CN103316219B (zh) | 2013-07-01 | 2013-07-01 | 一种治疗肺结核的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310285174.2A CN103316219B (zh) | 2013-07-01 | 2013-07-01 | 一种治疗肺结核的中药制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103316219A CN103316219A (zh) | 2013-09-25 |
CN103316219B true CN103316219B (zh) | 2015-08-12 |
Family
ID=49185452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310285174.2A Expired - Fee Related CN103316219B (zh) | 2013-07-01 | 2013-07-01 | 一种治疗肺结核的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103316219B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656404B (zh) * | 2013-10-28 | 2014-08-06 | 孟祥爱 | 一种治疗结核病的中药制剂及制备方法 |
CN103599391B (zh) * | 2013-11-14 | 2016-06-01 | 张志国 | 一种治疗放射性肺炎的中药组合物 |
CN103623233B (zh) * | 2013-12-16 | 2015-10-14 | 赵龙山 | 一种治疗肺结核的中药液 |
CN103784758B (zh) * | 2014-03-10 | 2016-02-03 | 成都中医药大学 | 一种治疗器官纤维化的药物组合物及其制备方法和用途 |
CN103860682B (zh) * | 2014-03-19 | 2015-10-28 | 吕桂兰 | 一种治疗肺结核的中药制剂及制备方法 |
CN104147255A (zh) * | 2014-08-23 | 2014-11-19 | 孙强 | 一种治疗重症肺部感染的药物组合物 |
CN105168610A (zh) * | 2015-08-26 | 2015-12-23 | 朱小芬 | 一种感冒咳嗽用的组合物及其制备方法 |
CN105250637A (zh) * | 2015-10-15 | 2016-01-20 | 张红 | 一种治疗肺结核的中药制剂 |
CN105194334A (zh) * | 2015-11-04 | 2015-12-30 | 臧海阳 | 一种治疗肺阴亏虚型肺痨的中药组合物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101062098A (zh) * | 2006-04-24 | 2007-10-31 | 赵赐安 | 复方金不换正气胶囊 |
CN100525817C (zh) * | 2007-04-18 | 2009-08-12 | 刘玉正 | 一种治疗结核病的药物组合物及其制备方法 |
CN101559186B (zh) * | 2009-05-27 | 2011-06-08 | 高春喜 | 一种治疗肺结核、肺炎及支气管炎的药物组合物 |
CN101982193B (zh) * | 2010-11-09 | 2012-04-25 | 吉林一正药业集团有限公司 | 一种治疗肺结核的中药组合物及其制备方法和应用 |
-
2013
- 2013-07-01 CN CN201310285174.2A patent/CN103316219B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103316219A (zh) | 2013-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103316219B (zh) | 一种治疗肺结核的中药制剂及其制备方法 | |
CN103417745B (zh) | 一种治疗急性胆囊炎的中药制剂及其制备方法 | |
CN103860978B (zh) | 一种治疗褥疮的中药制剂及其制备方法 | |
CN103520505B (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN102846824B (zh) | 一种治疗寒湿血瘀阻络型糖尿病足的中药组合物及其制备方法 | |
CN104815037A (zh) | 一种治疗风湿蕴毒型慢性湿疹的药物及其制备方法 | |
CN104840695A (zh) | 一种用于治疗仔猪白痢的药物组合物及其制备方法 | |
CN104587302A (zh) | 一种治疗急性阑尾炎的中药制剂 | |
CN104398980A (zh) | 一种治疗中风后偏瘫的中药制剂及其制备方法 | |
CN104147538A (zh) | 一种治疗湿热毒盛型糖尿病足的中药制剂及其制备方法 | |
CN104042971A (zh) | 用于治疗阴虚毒热型肺癌的药物组合物及其制备方法 | |
CN103055225B (zh) | 用于治疗耐药性肺结核病的中药及其制备方法 | |
CN105194460A (zh) | 治疗风湿热型痛风发作急性期的中药制剂 | |
CN104784549A (zh) | 用于治疗变应性鼻炎的内服中药 | |
CN103520427B (zh) | 一种治疗正虚邪盛型慢性骨髓炎的中药及其制备方法 | |
CN104000907B (zh) | 一种治疗慢性荨麻疹的中药及其制备方法 | |
CN103157062A (zh) | 一种治疗子宫肌瘤等妇科包块性疾病的药物组合物及其制备方法与应用 | |
CN104547384A (zh) | 一种治疗百草枯中毒的口服液及制备方法 | |
CN104800675A (zh) | 用于治疗活动期溃疡性结肠炎的药物 | |
CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN1327874C (zh) | 治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN110496200A (zh) | 一种治疗肺结核的中药组合物及其制备方法和应用 | |
CN104667183A (zh) | 治疗湿热邪滞型化脓性骨髓炎的药物制剂及其制备方法 | |
CN103520511A (zh) | 一种治疗瘀阻痰凝型甲状腺腺瘤的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HAO YANQIN Free format text: FORMER OWNER: ZHOU HANSHENG Effective date: 20150513 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Hao Yanqin Inventor before: Zhou Hansheng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHOU HANSHENG TO: HAO YANQIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150513 Address after: 276000 Linyi Tumour Hospital, Lanshan East Street, Lanshan District, Shandong, Linyi 6, China Applicant after: Hao Yanqin Address before: 233 Linyi Chest Hospital, Fenghuang street, Hedong District, Shandong, Linyi 276034, China Applicant before: Zhou Hansheng |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150812 Termination date: 20160701 |